Practices

Cases Investigated

Beasley Allen is currently investigating the following cases involving unsafe medications. However, our attorneys would like to investigate any claims of serious injury or death that may be the result of defective medical devices or drugs.

Litigation alleges GSK profits off billions in Zofran sales, subjects parents to unnecessary loss

October 11, 2017 - The underlying claim is that Zofran causes birth defects in babies born to women who used the drug while pregnant. Read More


Jury awards $140 million to Plaintiff in testosterone replacement therapy litigation

October 5, 2017 - A jury in Illinois federal court awarded Plaintiff Jeffrey Konrad $140 million in litigation involving testosterone replacement therapy (TRT). Read More


Dietary changes provide better, safer alternative than PPIs in treating acid-related disorders

October 4, 2017 - Dietary intervention may have as much benefit as PPIs in reducing laryngopharyngeal reflux (LPR) – a condition that occurs in a person who has gastroesophageal reflux disease (GERD). Read More


Doctors abandoning Invokana over increased risk of amputations

September 27, 2017 - The latest reported adverse side effect connected to Invokana – an increased risk of amputation – has led some doctors to stop prescribing the diabetes drug. Read More


New, contradictory evidence from Xarelto makers could lead to retrial for plaintiff

September 21, 2017 - There is an effective lab test to protect patients taking Xarelto, but that isn’t what jurors heard during last month’s trial against Johnson & Johnson’s Janssen Pharmaceuticals and... Read More


Taxotere MDL trial dates set

September 20, 2017 - Taxotere, a chemotherapy drug approved by the Food and Drug Administration (FDA) to treat breast cancer and other forms of cancer, has been linked to permanent hair loss. Read More


New trial for testosterone litigation starts next week

September 13, 2017 - Plaintiffs maintain that despite not being designed to treat symptoms of age-related testosterone decline, manufacturers marketed the products as “fountain of youth” drugs to lure men... Read More


No new trial for Janssen Pharmaceutical in $2.5 million Risperdal case

August 30, 2017 - The company was seeking a new trial as part of an effort to overturn a $2.5 million jury verdict that was awarded in 2015 to an Alabama man Austin Pledger. Read More


Navan Ward appointed to Plaintiffs Executive Committee for PPI litigation

August 25, 2017 - Proton Pump Inhibitor (PPI) drugs have been linked to kidney damage. Read More


Concern over Invokana adverse side effects continues to grow

August 25, 2017 - Reports of amputations connected to canagliflozin, the key ingredient in brand name medications Invokana and Invokamet, continue to underscore the drug’s dangers. Read More


back to top